Israel Englander Eagle Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 167,782 shares of EGRX stock, worth $134,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares

167,782

Previous 257,864 34.93%

Holding current value

$134,225

Previous $1.35 Million 30.5%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.34 - $5.6 $300,873 - $504,459	-90,082 Reduced 34.93%	167,782 $939,000
Q1 2024 May 15, 2024	SELL	$4.26 - $6.51 $1.13 Million - $1.72 Million	-264,538 Reduced 50.64%	257,864 $1.35 Million
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $1.11 Million - $3.66 Million	240,657 Added 85.42%	522,402 $2.73 Million
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $278,890 - $501,028	-15,721 Reduced 5.28%	281,745 $5.48 Million
Q1 2023 May 15, 2023	BUY	$25.06 - $34.09 $5.21 Million - $7.09 Million	207,963 Added 232.35%	297,466 $8.44 Million
Q4 2022 Feb 14, 2023	SELL	$24.98 - $39.77 $1.88 Million - $2.99 Million	-75,140 Reduced 45.64%	89,503 $2.62 Million
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $3.97 Million - $7.07 Million	-150,096 Reduced 47.69%	164,643 $4.35 Million
Q2 2022 Aug 15, 2022	BUY	$41.26 - $51.35 $12.5 Million - $15.5 Million	302,291 Added 2428.43%	314,739 $14 Million
Q1 2022 May 16, 2022	SELL	$44.58 - $52.6 $17,965 - $21,197	-403 Reduced 3.14%	12,448 $616,000
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $41,100 - $51,039	-897 Reduced 6.52%	12,851 $654,000
Q3 2021 Nov 15, 2021	SELL	$43.79 - $55.78 $2.33 Million - $2.97 Million	-53,159 Reduced 79.45%	13,748 $767,000
Q2 2021 Aug 16, 2021	SELL	$36.86 - $44.5 $722,382 - $872,111	-19,598 Reduced 22.66%	66,907 $2.86 Million
Q1 2021 May 17, 2021	BUY	$40.32 - $50.97 $964,010 - $1.22 Million	23,909 Added 38.2%	86,505 $3.61 Million
Q4 2020 Feb 16, 2021	BUY	$41.72 - $51.34 $1.5 Million - $1.84 Million	35,886 Added 134.35%	62,596 $2.92 Million
Q3 2020 Nov 16, 2020	SELL	$37.02 - $51.28 $3.17 Million - $4.39 Million	-85,555 Reduced 76.21%	26,710 $1.14 Million
Q2 2020 Aug 14, 2020	BUY	$43.24 - $55.02 $4.59 Million - $5.84 Million	106,134 Added 1731.1%	112,265 $5.39 Million
Q1 2020 May 14, 2020	BUY	$34.37 - $60.07 $210,722 - $368,289	6,131 New	6,131 $282,000
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $1.58 Million - $1.87 Million	-29,021 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$53.25 - $59.98 $963,931 - $1.09 Million	18,102 Added 165.78%	29,021 $1.64 Million
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $8.48 Million - $10.6 Million	-182,029 Reduced 94.34%	10,919 $608,000
Q1 2019 May 14, 2019	SELL	$38.66 - $51.82 $3.55 Million - $4.76 Million	-91,805 Reduced 32.24%	192,948 $9.74 Million
Q4 2018 Feb 14, 2019	BUY	$36.72 - $67.73 $10 Million - $18.5 Million	273,294 Added 2384.97%	284,753 $11.5 Million
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $763,742 - $960,951	11,459 New	11,459 $794,000
Q1 2018 May 15, 2018	SELL	$52.16 - $66.86 $1.09 Million - $1.39 Million	-20,841 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$49.6 - $60.87 $1.03 Million - $1.27 Million	20,841	20,841 $1.11 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

9.73M

Call Options Held

1.01M

Put Options Held

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $10.4M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account